88 related articles for article (PubMed ID: 17387582)
1. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 and Risk of Morbidity and Mortality From Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg.
Mukama T; Srour B; Johnson T; Katzke V; Kaaks R
J Clin Endocrinol Metab; 2023 Sep; 108(10):e1092-e1105. PubMed ID: 37066827
[TBL] [Abstract][Full Text] [Related]
3. Linear growth in relation to the circulating concentration of insulin-like growth factor-I in young children with acyanotic congenital heart disease with left to right shunts before versus after surgical intervention.
Soliman AT; Elawwa A; Khella A; Saeed S; Yassin H
Indian J Endocrinol Metab; 2012 Sep; 16(5):791-5. PubMed ID: 23087866
[TBL] [Abstract][Full Text] [Related]
4. A Functional Interplay between IGF-1 and Adiponectin.
Orrù S; Nigro E; Mandola A; Alfieri A; Buono P; Daniele A; Mancini A; Imperlini E
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036907
[TBL] [Abstract][Full Text] [Related]
5. FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease.
Januszewski AS; Watson CJ; O'Neill V; McDonald K; Ledwidge M; Robson T; Jenkins AJ; Keech AC; McClements L
Sci Rep; 2020 Dec; 10(1):21655. PubMed ID: 33303872
[TBL] [Abstract][Full Text] [Related]
6. Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency.
Guevara-Aguirre J; Mishra A; Canepa M; Guevara C; Villacres Á; Guevara A; Peña G; Lescano D; Kopchick JJ; Balasubramanian P; Longo VD
Med; 2024 Apr; ():. PubMed ID: 38677286
[TBL] [Abstract][Full Text] [Related]
7. Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy.
Hayhurst WS; Ahmed A
Springerplus; 2015; 4(1):536. PubMed ID: 26413442
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase in chronic kidney disease.
Madhusudhana Rao A; Anand U; Anand CV
Indian J Clin Biochem; 2011 Jan; 26(1):28-31. PubMed ID: 22211010
[TBL] [Abstract][Full Text] [Related]
9. Association between insulin-like growth factor-1 and systolic blood pressure in children and adolescents with short stature.
Zhao Q; Zhang M; Chu Y; Sun H; Ban B
J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1112-1119. PubMed ID: 33794039
[TBL] [Abstract][Full Text] [Related]
10. Human conditions of insulin-like growth factor-I (IGF-I) deficiency.
Puche JE; Castilla-Cortázar I
J Transl Med; 2012 Nov; 10():224. PubMed ID: 23148873
[TBL] [Abstract][Full Text] [Related]
11. Exploring metabolic dysfunction in chronic kidney disease.
Slee AD
Nutr Metab (Lond); 2012 Apr; 9(1):36. PubMed ID: 22537670
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.
Osorio A; Ortega E; de Haro T; Torres JM; Sánchez P; Ruiz-Requena E
Mol Cell Biochem; 2011 Jul; 353(1-2):59-63. PubMed ID: 21547454
[TBL] [Abstract][Full Text] [Related]
13. Association between IGF-1 and chronic kidney disease among US adults.
Teppala S; Shankar A; Sabanayagam C
Clin Exp Nephrol; 2010 Oct; 14(5):440-4. PubMed ID: 20567872
[TBL] [Abstract][Full Text] [Related]
14. Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.
Abdulle AM; Gillett MP; Abouchacra S; Sabri SM; Rukhaimi MA; Obineche EN; Singh J
Mol Cell Biochem; 2007 Aug; 302(1-2):195-201. PubMed ID: 17387582
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
[TBL] [Abstract][Full Text] [Related]
17. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
18. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?
Janssen JA; Lamberts SW
Eur J Endocrinol; 2002 Apr; 146(4):467-77. PubMed ID: 11916613
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology.
Beige J; Heipmann K; Stumvoll M; Körner A; Kratzsch J
Expert Opin Ther Targets; 2009 Feb; 13(2):163-73. PubMed ID: 19236235
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
